Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam vs propofol sedation in obese patients undergoing colonoscopy
ChiCTR2100049951Phase 4Not yet recruiting
- Sponsor
- The First Affiliated Hospital of Zhengzhou University
- Start
- Aug 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of remimazolam in obesity (2 arms), sponsored by The First Affiliated Hospital of Zhengzhou University. Primary endpoint: oxygen-desaturation episodes. Planned start Aug 2021; status: not yet recruiting.
02
Drugs
remimazolam
03
Conditions
obesity
Beyond the preview
Go deeper on ChiCTR2100049951.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100049951.